(Date:12/4/2008)... MedImmune today announced that,it has initiated ...asthma to,determine the safety of subcutaneous do...t targets the interleukin-5 receptor (IL-5R). Prec...thway may lead to a targeted approach for,treatin... of this antibody. , "Asthma can be a very ...
(Date:12/4/2008)...Full Year 2009 Earnings Guidance , , , ... DuPont, (NYSE: DD ) today announced further ac...engthen the company,s competitiveness in 2009, inc...d provided earnings guidance for the fourth quarte...global decline in construction and motor vehicle s...
(Date:12/4/2008)...on Sciences, Inc. today announced,that its partne...d a Phase I,clinical trial of GS9411 in healthy v... of the investigational compound. GS9411 is desig...t of pulmonary disease. Previously known as,P-68...locker discovered by,Parion, a privately held pha...
(Date:12/4/2008).../ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: A... endocrine therapy and oncology, today announced t...ill take part in a panel discussion titled, "Repla... the upcoming RBC Capital Markets 2008 Healthcare ... pm (eastern time) at the Westin Times Square Hote...
Breaking Biology Technology:MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 2DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 4DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 5DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 6Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3...ailFoundry , a line of anti-spam equipment and ser...w includes a plan for small businesses. MailFoundr...ccounts. , ,To use the service, a company would ro...ould be filtered and then sent back to the company... hosted services, MailFoundry also offers a rack-m...
...g an Oracle-based e-mail installation and trying t...fees, based on a pilot program that lasted for at ... insurmountable technical difficulties cropped up....inistration Secretary Steve Bablitch said in a let...lidated e-mail system, which would have served 44,...
...ypus Technologies has appointed Rich Schifreen, vi...poration, to its board of directors. , ,The firms ...typus develops slides and other surfaces using na...a new liquid crystal technology. Mirus focuses o...oined Mirus in 2005. Before that, he was director ...
...cline in research revenue led Third Wave Technolo...nts a share, but because the loss was expected sha...ompany in transition, Third Wave expected somethin...nical market, rather than research and a new CEO....ompared to 2004 revenue of $46.5 million. Its net ...
Other Biology Technology:Oracle out, Microsoft in for state e-mail project 2...lgae gene into neurons of the tiny, transparent ne...licit specific behavioral responses by simply illu...he way for better understanding of how neurons com...ulate behavior in intact, living organisms. Genera...ity and function of specific neurons during partic...
...on the time when the most recent common ancestor o...impanzees -- lived. Scientists at Arizona State a... this split between 5 and 7 million years ago -- a...lection of molecular and fossil studies, which hav...ion years ago. , The scientists analyzed the large...
...icated genes provides insight into mechanisms of e...l copy of a gene in an organism,s genome, the dupl...herwise rendered nonfunctional in order to prevent...eostasis. In some cases, however, gene duplicates... the biological and evolutionary forces behind the...
...ty from acute stroke may be delivered much later t...otential advance needed to benefit more stroke vic...rida found that human umbilical cord blood cells a...eatly curbed the brain,s inflammatory response, re...atly improved recovery. The rats, inflammatory res...
Other Biology News:Algal protein in worm neurons allows remote control of behavior by light 2Scientists narrow the time limits for the human and chimpanzee split 2Scientists narrow the time limits for the human and chimpanzee split 3Fitting in: Newly evolved genes adopt a variety of strategies to remain in the gene pool 2Cord blood cells may widen treatment window for stroke 2DAP12 Market Segment: Protein Kinases
Rabbit polyclonal to Flagellin ( Abpromise for all tested applications). Antigen: Synthetic peptide from the flagellin C terminal domain of Burkholderia pseudomallei.
Naphthol Blue Black, CI 20470
Novagen's Calf Liver tRNA is qualified for use in reticulocyte lysates for in vitro translation, and is the same supplement used in the Red Nova Lysate .
Biology Products: